Your browser doesn't support javascript.
loading
Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.
El Kasmi, Karim C; Pugliese, Steven C; Riddle, Suzette R; Poth, Jens M; Anderson, Aimee L; Frid, Maria G; Li, Min; Pullamsetti, Soni S; Savai, Rajkumar; Nagel, Maria A; Fini, Mehdi A; Graham, Brian B; Tuder, Rubin M; Friedman, Jacob E; Eltzschig, Holger K; Sokol, Ronald J; Stenmark, Kurt R.
Afiliação
  • El Kasmi KC; Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045; Karim.Elkasmi@UCDenver.edu Kurt.Stenmark@UCDenver.edu.
  • Pugliese SC; Division of Critical Care Medicine/Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Medicine, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Riddle SR; Division of Critical Care Medicine/Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Medicine, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Poth JM; Division of Critical Care Medicine/Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Medicine, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Anderson AL; Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Frid MG; Division of Critical Care Medicine/Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Medicine, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Li M; Division of Critical Care Medicine/Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Medicine, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Pullamsetti SS; Department of Lung Development and Remodeling, Max-Planck Institute for Heart and Lung Research, University of Giessen and Marburg Lung Center, German Center for Lung Research, D-61231 Bad Nauheim, Germany;
  • Savai R; Department of Lung Development and Remodeling, Max-Planck Institute for Heart and Lung Research, University of Giessen and Marburg Lung Center, German Center for Lung Research, D-61231 Bad Nauheim, Germany;
  • Nagel MA; Department of Neurology, University of Colorado Denver, School of Medicine, Aurora, CO 80045;
  • Fini MA; Division of Critical Care Medicine/Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Medicine, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Graham BB; Program in Translational Lung Research, Department of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Tuder RM; Program in Translational Lung Research, Department of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Friedman JE; Division of Biochemistry and Molecular Genetics, Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045; and.
  • Eltzschig HK; Department of Anesthesiology, School of Medicine, University of Colorado Denver, Aurora, CO 80045.
  • Sokol RJ; Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045;
  • Stenmark KR; Division of Critical Care Medicine/Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Medicine, School of Medicine, University of Colorado Denver, Aurora, CO 80045; Karim.Elkasmi@UCDenver.edu Kurt.Stenmark@UCDenver.edu.
J Immunol ; 193(2): 597-609, 2014 Jul 15.
Article em En | MEDLINE | ID: mdl-24928992
ABSTRACT
Macrophage accumulation is not only a characteristic hallmark but is also a critical component of pulmonary artery remodeling associated with pulmonary hypertension (PH). However, the cellular and molecular mechanisms that drive vascular macrophage activation and their functional phenotype remain poorly defined. Using multiple levels of in vivo (bovine and rat models of hypoxia-induced PH, together with human tissue samples) and in vitro (primary mouse, rat, and bovine macrophages, human monocytes, and primary human and bovine fibroblasts) approaches, we observed that adventitial fibroblasts derived from hypertensive pulmonary arteries (bovine and human) regulate macrophage activation. These fibroblasts activate macrophages through paracrine IL-6 and STAT3, HIF1, and C/EBPß signaling to drive expression of genes previously implicated in chronic inflammation, tissue remodeling, and PH. This distinct fibroblast-activated macrophage phenotype was independent of IL-4/IL-13-STAT6 and TLR-MyD88 signaling. We found that genetic STAT3 haplodeficiency in macrophages attenuated macrophage activation, complete STAT3 deficiency increased macrophage activation through compensatory upregulation of STAT1 signaling, and deficiency in C/EBPß or HIF1 attenuated fibroblast-driven macrophage activation. These findings challenge the current paradigm of IL-4/IL-13-STAT6-mediated alternative macrophage activation as the sole driver of vascular remodeling in PH, and uncover a cross-talk between adventitial fibroblasts and macrophages in which paracrine IL-6-activated STAT3, HIF1α, and C/EBPß signaling are critical for macrophage activation and polarization. Thus, targeting IL-6 signaling in macrophages by completely inhibiting C/EBPß or HIF1α or by partially inhibiting STAT3 may hold therapeutic value for treatment of PH and other inflammatory conditions characterized by increased IL-6 and absent IL-4/IL-13 signaling.
Assuntos
Fibroblastos/imunologia; Hipertensão Pulmonar/imunologia; Ativação de Macrófagos/imunologia; Macrófagos/imunologia; Animais; Animais Recém-Nascidos; Proteína beta Intensificadora de Ligação a CCAAT/genética; Proteína beta Intensificadora de Ligação a CCAAT/imunologia; Proteína beta Intensificadora de Ligação a CCAAT/metabolismo; Bovinos; Linhagem Celular Tumoral; Células Cultivadas; Meios de Cultivo Condicionados/metabolismo; Meios de Cultivo Condicionados/farmacologia; Fibroblastos/metabolismo; Fibrose/genética; Fibrose/imunologia; Fibrose/metabolismo; Expressão Gênica/efeitos dos fármacos; Expressão Gênica/genética; Expressão Gênica/imunologia; Humanos; Hipertensão Pulmonar/genética; Hipertensão Pulmonar/metabolismo; Subunidade alfa do Fator 1 Induzível por Hipóxia/genética; Subunidade alfa do Fator 1 Induzível por Hipóxia/imunologia; Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo; Immunoblotting; Inflamação/genética; Inflamação/imunologia; Inflamação/metabolismo; Interleucina-6/metabolismo; Interleucina-6/farmacologia; Ativação de Macrófagos/efeitos dos fármacos; Ativação de Macrófagos/genética; Macrófagos/metabolismo; Camundongos Endogâmicos BALB C; Camundongos Endogâmicos C57BL; Camundongos Knockout; Fenótipo; Ratos Endogâmicos WKY; Reação em Cadeia da Polimerase Via Transcriptase Reversa; Fator de Transcrição STAT3/genética; Fator de Transcrição STAT3/imunologia; Fator de Transcrição STAT3/metabolismo

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibroblastos / Hipertensão Pulmonar / Ativação de Macrófagos / Macrófagos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibroblastos / Hipertensão Pulmonar / Ativação de Macrófagos / Macrófagos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article